NCT02741245View on ClinicalTrials.gov

A Study of the Efficacy and Safety of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-832)

PHASE3CompletedINTERVENTIONAL
Enrollment

321

Participants

Timeline

Start Date

June 9, 2016

Primary Completion Date

January 18, 2017

Study Completion Date

January 18, 2017

Conditions
Hypercholesterolemia
Interventions
DRUG

Ezetimibe 10 mg

DRUG

Rosuvastatin 2.5 mg

DRUG

Placebo for Ezetimibe

DRUG

Placebo for Rosuvastatin

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT02741245 - A Study of the Efficacy and Safety of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-832) | Biotech Hunter | Biotech Hunter